Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

Rhea-AI Summary

Tharimmune (NASDAQ: THAR) announced leadership changes effective Feb 5, 2026: Mark Wendland was elected Chairman of the Board and Angela Radkowski was named Chief Operating Officer. Vincent LoPriore will transition from Chairman to a Board member. Radkowski joins from DRW and Citadel and will lead operations, the Canton Network quarterly research initiative, and Super Validator activation. Tharimmune reaffirmed its Canton Network-aligned digital asset treasury strategy established in November 2025, plans CC acquisition, Super Validator operations, and investments in Canton-based applications. Tharimmune is the first publicly traded company supported by the Canton Foundation.

Positive

• Mark Wendland elected Chairman effective Feb 5, 2026
• Angela Radkowski appointed COO to lead operations and Super Validator activation
• Company established a digital asset treasury strategy in November 2025
• Firm intends to acquire Canton Coin (CC) and operate as a Super Validator
• First publicly traded company supported by the Canton Foundation

Negative

• None.

News Market Reaction

+5.34%

3 alerts

+5.34% News Effect

+$11M Valuation Impact

$222M Market Cap

1.0x Rel. Volume

On the day this news was published, THAR gained 5.34%, reflecting a notable positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $11M to the company's valuation, bringing the market cap to $222M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Shelf registration: $2,000,000,000 PIPE transaction: $545 million ATM capacity: $64,910,161 +5 more

8 metrics

Shelf registration $2,000,000,000 Maximum aggregate amount under S-3 shelf filed January 9, 2026

PIPE transaction $545 million Recent PIPE deal partly funded with Canton Coin

ATM capacity $64,910,161 Maximum common stock that can be sold via ATM program

Shares outstanding 37,386,114 Common shares outstanding as of January 6, 2026 (shelf filing)

LCV warrants 16,500,504 warrants Warrants exercisable at $0.0001 per share, subject to 9.99% blocker

Equity plan increase 7,000,000 shares Additional shares for 2023 Omnibus Equity Incentive Plan approved Jan 30, 2026

Registered offering size $55 million Underwritten registered offering announced January 20–22, 2026

ARK ownership 3,252,033 shares (8.92%) Beneficial ownership reported on Schedule 13G as of 12/31/2025

Market Reality Check

Price: $4.48 Vol: Volume 1,357,251 is in li...

normal vol

$4.48 Last Close

Volume Volume 1,357,251 is in line with 20-day average of 1,347,189 (relative 1.01x). normal

Technical Shares at $3.93, trading above the 200-day MA of $2.51 despite a -16.91% 24h decline.

Peers on Argus

THAR fell 16.91% while biotech peers like MTVA -6.49%, BLRX -3.31%, LPCN -3.98%,...

1 Up

THAR fell 16.91% while biotech peers like MTVA -6.49%, BLRX -3.31%, LPCN -3.98%, and SYBX -0.8% also declined. The downside pressure appears sector-linked, but THAR’s drop is materially larger than peers.

Common Catalyst No same-day peer news headlines were recorded; sector weakness appears broader rather than headline-driven.

Historical Context

5 past events · Latest: Feb 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 05	Earnings report	Positive	-16.9%	Strong revenue, net income, dividend increase and buyback authorization at TW.
Feb 02	Board changes	Positive	+12.1%	Election of two directors with regulatory and capital-markets expertise.
Jan 26	Network role update	Positive	+9.1%	Approval to operate as a Super Validator on the Canton Network.
Jan 22	Capital raise close	Neutral	+7.9%	Closing of a $55M underwritten registered direct offering to fund Canton strategy.
Jan 20	Offering pricing	Neutral	+0.0%	Pricing of $55M underwritten registered offering for growth capital.

Pattern Detected

Recent Canton-related and governance updates have often coincided with positive price moves, while a strong fundamental earnings print in another name saw a negative reaction.

Recent Company History

Over the past few weeks, the stock’s news flow has centered on capital raising and the Canton Network strategy. A $55M underwritten offering and related pricing in January 2026 supported its Canton-centric digital asset treasury efforts, with modestly positive to flat price reactions. The Jan 26 Super Validator announcement and Feb 2 board additions both saw bullish reactions. Today’s leadership changes extend this governance build-out around the same Canton-focused roadmap.

Regulatory & Risk Context

Active S-3 Shelf · $2,000,000,000

Shelf Active

Active S-3 Shelf Registration 2026-01-09

$2,000,000,000 registered capacity

An effective S-3 shelf filed on 2026-01-09 allows Tharimmune to offer up to $2,000,000,000 of various securities over time. The company has already tapped this shelf via a 424B5 offering on 2026-01-20, and also maintains an ATM program, highlighting significant authorized capacity for future capital raises tied to its Canton-centric and clinical strategies.

Market Pulse Summary

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with how...

Analysis

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with how prior Canton-related milestones and governance enhancements have been received, with earlier Super Validator and board updates seeing gains of 9.12% and 12.07%. Investors might view the new Chairman/COO structure as reinforcing execution around the digital asset treasury and Canton Network strategy. However, substantial capacity under the $2,000,000,000 shelf and existing ATM program could remain an overhang if further equity issuance occurs.

Key Terms

digital asset, blockchain, treasury strategy

3 terms

digital asset financial

"its Canton Network-aligned digital asset strategy to help modernize financial"

A digital asset is a representation of value or rights that exists only in electronic form—like digital versions of cash, stocks, or collectibles kept in a virtual wallet. They are transferred and recorded using computer systems that make copying or tampering difficult, and can include currencies, tokenized shares, or unique digital items. Investors care because digital assets can offer new ways to diversify, trade and raise capital, but they also bring different risks around price swings, custody and regulation.

blockchain technical

"while enabling secure, scalable blockchain adoption. I am excited to join"

A blockchain is a digital record-keeping system that securely stores information across many computers, making it difficult to alter or tamper with. Think of it like a shared, unchangeable ledger that everyone can see and verify, ensuring transparency and trust. For investors, this technology offers a way to securely track transactions and assets without relying on a central authority, potentially reducing costs and increasing security.

treasury strategy financial

"digital asset treasury strategy in November 2025. In addition to driving"

A treasury strategy is a plan that organizations use to manage their money, investments, and financial risks to ensure they have enough funds when needed. It helps them make smart decisions about saving, spending, and borrowing, much like a household planning a budget to meet both everyday expenses and future goals. For investors, a well-crafted treasury strategy indicates financial stability and effective management of resources.

AI-generated analysis. Not financial advice.

Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy

Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion

NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, who will transition to a member of the Board after serving as Chairman since May 9, 2025.

In her role as COO, Ms. Radkowski will oversee operational control functions and enterprise processes, including the implementation of Tharimmune's Canton Network quarterly research initiative and Super Validator activation.

"I am honored to assume the role of Chairman as we continue executing on our Canton Network-aligned digital asset strategy to help modernize financial market infrastructure," said Mark Wendland. "The Board, under the dedicated leadership of Vincent LoPriore, has demonstrated an unwavering commitment to building a governance and operating structure capable of supporting our digital asset treasury strategy, and Angela's appointment adds critical leadership at a pivotal moment. Her experience scaling complex financial systems will be instrumental as we advance institutional adoption of Canton Network and drive value for shareholders."

Prior to her appointment, Ms. Radkowski served as Operations Strategy Lead and Chief of Staff to the Chief Operating Officer at DRW Holdings LLC, advising senior leadership, coordinating cross-functional communication, and managing high-priority, enterprise-level initiatives. Ms. Radkowski previously held positions within Citadel LLC's Treasury and Engineering organizations, where she was responsible for coordinating enterprise deliverables involving optimization, data engineering, and technology upgrades.

Ms. Radkowski added, "The Canton Network introduces a new model for institutional finance — one that addresses the limitations of legacy infrastructure while enabling secure, scalable blockchain adoption. I am excited to join Tharimmune and help build the operational foundation required to support this transformation."

Tharimmune established its differentiated digital asset treasury strategy in November 2025. In addition to driving value through CC acquisition and operating as a Super Validator, Tharimmune intends to invest in applications built on the Canton Network that accelerate institutional utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.

About Tharimmune
Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.

Contacts

Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com

Investors:
ir@tharimmune.com

X: @TharimmuneInc
LinkedIn: https://www.linkedin.com/company/tharimmune-inc/
Website: https://tharimmune.com/

View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-appoints-mark-wendland-chairman-of-the-board-and-names-angela-radkowski-chief-operating-officer-302681307.html

SOURCE Tharimmune, Inc.

FAQ

Who is the new Chairman of Tharimmune (THAR) and when did the change take effect?

Mark Wendland was elected Chairman of the Board, effective Feb 5, 2026. According to Tharimmune, he succeeds Vincent LoPriore, who will remain on the Board, reflecting a planned leadership transition while maintaining board continuity.

What are Angela Radkowski's responsibilities as COO of Tharimmune (THAR)?

Angela Radkowski will oversee operational control functions and enterprise processes at Tharimmune. According to Tharimmune, she will implement the Canton Network quarterly research initiative and lead Super Validator activation to support institutional platform expansion.

How does Tharimmune (THAR) plan to use Canton Coin and the Canton Network?

Tharimmune intends to acquire Canton Coin (CC) and operate as a Super Validator on the Canton Network. According to Tharimmune, the strategy targets digitizing traditional markets and investing in Canton-based applications to accelerate institutional adoption.

What is Tharimmune's (THAR) corporate relationship with the Canton Foundation?

Tharimmune is the first publicly traded company supported by the Canton Foundation. According to Tharimmune, this support underpins its Canton Network-aligned digital asset treasury strategy launched in November 2025.

What relevant experience does Tharimmune's (THAR) new COO bring from prior roles?

Angela Radkowski brings operations strategy and chief-of-staff experience from DRW and treasury and engineering roles at Citadel. According to Tharimmune, her background includes enterprise deliverables, data engineering coordination, and scaling complex financial systems.